Clinical Evaluation of Aspheric Heparin Surface Modified Hydrophobic Foldable Intra Ocular Lens (IOL) in Diabetic Patients

AIIMS0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Diabetes mellitus
•2 Age â?? 45 years or above
•3 Presence of cataract sufficient to cause visual symptoms in patients with diabetes mellitus requiring medical control
•4 Patients with no evidence of diabetic retinopathy or mild to moderate non proliferative diabetic retinopathy without maculopathy
•5 Patient willing to give informed consent
•6 Patients willing to come for follow ups

•Presence of coexistent ocular disease likely to modify visual acuity other than diabetic retinopathy (eg, age-related macular degeneration, amblyopia, or retinal venous occlusion)
•Proliferative or very severe non proliferative diabetic retinopathy and clinically significant macular edema
•Iris neovascularization
•Prior intraocular surgery (eg, trabeculectomy or vitrectomy
•Intraocular tumors
•Pseudoexfoliation syndrome
•Intraoperative capsule complications such as anterior or posterior capsule tears
•Use of oral steroids or glaucoma medications
•Patients not giving consent for the study
•Patients not willing for follow up

发起方